Decision Diagnostics Corp. (DECN)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 27, 2026
0.00%
Market Cap 380.00
Revenue (ttm) 2.13M
Net Income (ttm) -8.29M
Shares Out 380.49M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,000
Average Volume 99,340
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0001
Beta -0.04
RSI 48.15
Earnings Date n/a

About Decision Diagnostics

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of d... [Read more]

Sector Healthcare
Founded 2000
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol DECN
Full Company Profile

Financial Performance

In 2020, Decision Diagnostics's revenue was $1.98 million, a decrease of -16.82% compared to the previous year's $2.38 million. Losses were -$29.67 million, 847.2% more than in 2019.

Financial Statements

News

There is no news available yet.